{
    "code": "01026167",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01026167",
    "time": "2023-05-05 04:51:11",
    "許可證字號": "衛署藥製字第026167號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "117\/04\/30",
    "發證\/登錄日期": "71\/09\/03",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00102616702",
    "中文品名": "欣普列錠４毫克（甲基培尼皮質醇）",
    "英文品名": "Shinpre Tablets 4mg (Methylprednisolone)",
    "適應症": "膠原病：慢性關節僂麻質斯、僂麻質熱、播種性紅斑性狼瘡、過敏性疾患：氣喘、血清病、蕁麻疹、血液疾患：紫斑病、白血病、急、慢性淋巴性白血病、腎性症候群之腎疾患、重症感染症（危急時）潰瘍性大腸炎、外科、侵襲休克、重症火傷、皮膚疾患：接觸性皮膚炎、急性濕疹、眼疾患：眼瞼結膜疾患、虹彩炎、神經皮膚炎、脂漏性濕疹",
    "劑型": "110錠劑",
    "包裝": "瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "METHYLPREDNISOLONE",
    "限制項目": "01國　產 09委託製造 1R不得製造",
    "申請商名稱": "美西製藥有限公司",
    "申請商地址": "高雄市仁武區仁武里工業一路９號",
    "主製造廠": [
        {
            "製造廠名稱": "美西製藥有限公司",
            "製造廠廠址": "高雄市仁武區仁武里工業一路９號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30043200002 其他醫藥製劑，含有腎上腺皮質類固醇荷爾蒙及其衍生物或結構式類似者Other medicaments, containing corticosteroid hormones, their derivatives or structural analogues",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6804001300",
            "成分名稱": "METHYLPREDNISOLONE",
            "含量描述": "4",
            "含量": "4.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "欣普列仿單-104-12-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01026167&Seq=001&Type=9"
        }
    ]
}